recent concordia deal ..similar to what i expect from Aralez The deal is a mammoth one for Concordia because it roughly doubles the size of the company. Concordia’s market cap before the deal was announced was in the region of $3.7-billion.
“This acquisition is a key milestone and pivotal turning point in Concordia’s strategy, said Mark Thompson, CEO, of Concordia in a statement.
Concordia, like Valeant Pharmaceuticals Inc. has been on an acquisition spree since going public. It’s a strategy that shareholders have richly rewarded the company for. In March the company paid $1.2-billion (U.S.) to a acquire a suite of products from privately held, Covis Pharma.
Read more at https://www.stockhouse.com/companies/bullboard/v.nph/vanc-pharmaceuticals-inc#z5d23VPCp8bdBK6i.99